Citation Impact
Citing Papers
Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery
2007 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit
2002
Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction
2004
Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure?
2011
Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients
2000
Pathophysiology of acute wound healing
2007 Standout
Procalcitonin and neopterin as indicators of infection in critically ill patients
2002
Pediatric sepsis and multiple organ dysfunction syndrome
2001
Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned
2001
Sepsis biomarkers: a review
2010 Standout
In vivo total antioxidant capacity: comparison of different analytical methods1
1999
Procalcitonin used as a marker of infection in the intensive care unit
1999
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Procalcitonin as a marker of the systemic inflammatory response to infection
2000
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
2003 Standout
Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock
2000
Semi-quantitative Procalcitonin Test for the Diagnosis of Bacterial Infection: Clinical Use and Experience in Japan
2010
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
2013 Standout
Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial
2004
Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery
2005
Role of C-Reactive Protein at Sites of Inflammation and Infection
2018 Standout
Procalcitonin and cytokine levels: Relationship to organ failure and mortality in pediatric septic shock
2000
The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: A tool for distinguishing necrotizing fasciitis from other soft tissue infections*
2004 Standout
Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study
2008
Evidence of neutrophil functional defect despite inflammation in stable cirrhosis
2011
Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis
2005 Standout
Natural Substrates of Dipeptidyl Peptidase IV
2002
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome
2003 Standout
Oxidative stress and gene expression in sepsis
2003
Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia
2004
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779]
2006
Six at Six: Interleukin-6 Measured 6 H After the Initiation of Sepsis Predicts Mortality Over 3 Days
2002
Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections
2006 Standout
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation
2004 Standout
Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia
2005 Standout
C-reactive protein as a marker of infection in critically ill patients
2005
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
Procalcitonin serum levels after out-of-hospital cardiac arrest
2003
Predictive value of antithrombin III and serum C-reactive protein concentration in critically ill patients with suspected sepsis
2002
d-dimer is a significant prognostic factor in patients with suspected infection and sepsis
2012
Decrease of serum dipeptidylpeptidase activity in severe sepsis patients: relationship to procalcitonin
2002
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics*
2005 Standout
Procalcitonin release patterns in a baboon model of trauma and sepsis: Relationship to cytokines and neopterin
2000
Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study
2006
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Ageing and infection
2002 Standout
Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections
1999
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Serum procalcitonin levels in bacterial and abacterial meningitis
2000
European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support
2010 Standout
Markers for Sepsis Diagnosis: What is Useful?
2006
C-reactive protein: a valuable marker of sepsis
2002
Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 as a Marker of Microbial Infection
2004 Standout
Infection Probability Score (IPS): A method to help assess the probability of infection in critically ill patients*
2003
Procalcitonin in preoperative diagnosis of abdominal sepsis
2007
Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications
2002
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial
2009
Fluorescence probes used for detection of reactive oxygen species
2005 Standout
INCREASED PLASMA LEVELS OF SOLUBLE TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 AND PROCALCITONIN AFTER CARDIAC SURGERY AND CARDIAC ARREST WITHOUT INFECTION
2007
The Pathophysiology and Treatment of Sepsis
2003 Standout
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6
2000
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
2003 Standout
Patients with acute on chronic liver failure display ‘sepsis-like’ immune paralysis
2004
Serum procalcitonin in children with suspected sepsis: A comparison with C-reactive protein and neutrophil count*
2003
Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis
2006
Plasma procalcitonin and C-reactive protein in acute septic shock: Clinical and biological correlates
2002
Immune cells: free radicals and antioxidants in sepsis
2004
Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: Cause, consequence, or epiphenomenon?
2006 Standout
Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis
2002
IN VITRO EFFECTS OF EICOSANOIDS DERIVED FROM DIFFERENT 20-CARBON FATTY ACIDS ON PRODUCTION OF MONOCYTE-DERIVED CYTOKINES IN HUMAN WHOLE BLOOD CULTURES
2002
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
Procalcitonin in the diagnosis of inflammation in intensive care units
2006
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine
2014 Standout
The Significance of Vasoactive Intestinal Peptide in Immunomodulation
2004
Antioxidant activity of sulfated polysaccharide fractions extracted from Laminaria japonica
2007 Standout
Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis
2008 Standout
Prognosis of community acquired pneumonia (CAP): Value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response
2007 Standout
Procalcitonin Kinetics as a Prognostic Marker of Ventilator-associated Pneumonia
2004
Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected Sepsis
2001
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Reliability of Procalcitonin as a Severity Marker in Critically Ill Patients with Inflammatory Response
2002
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein
2004
Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: A randomized controlled trial
2011
Does Serum Procalcitonin Have a Role in Evaluating the Severity of Acute Pancreatitis? A Question Revisited
2006
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock
2005
Toward Resolving the Challenges of Sepsis Diagnosis
2004
Interleukin 13 and inflammatory markers in human sepsis
2004
Serum IL-1β, IL-6, IL-8, and TNF-α Levels in Early Diagnosis and Management of Neonatal Sepsis
2007
Diagnostic Efficacy and Prognostic Value of Serum Procalcitonin Concentration in Patients With Suspected Sepsis
2008
Extending Applicability of the Oxygen Radical Absorbance Capacity (ORAC−Fluorescein) Assay
2003 Standout
Point-of-Care Diagnostics for Global Health
2008 Standout
Diagnostic and prognostic value of procalcitonin in patients with septic shock
2004
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Invited Review: Oxidation of Biological Systems: Oxidative Stress Phenomena, Antioxidants, Redox Reactions, and Methods for Their Quantification
2002 Standout
Comparative Study of Antioxidant Properties and Total Phenolic Content of 30 Plant Extracts of Industrial Interest Using DPPH, ABTS, FRAP, SOD, and ORAC Assays
2009 Standout
Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS
1999
Altered immune function of monocytes in different stages of patients with acute on chronic liver failure
2006
Enhanced CXC Chemokine Responses of Human Colonic Epithelial Cells to Locus of Enterocyte Effacement-Negative Shiga-Toxigenic Escherichia coli
2003
Early identification of bacteremia by biochemical markers of systemic inflammation
2001
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
2013
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Plasma Endothelin-1 Levels in Septic Patients
2007
Works of M. Oberhoffer being referenced
Outcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsis
1999
Total plasma antioxidant capacity is not always decreased in sepsis
1998
Molecular Aspects and Natural Source of Procalcitonin
1999
Procalcitonin
1998
Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro
1999
Procalcitonin — A new indicator of the systemic response to severe infections
1997
Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicate intracellular procalcitonin content
1999
INFLAMMATORY AND IMMUNOLOGICAL PARAMETERS IN CHILDREN WITH HAEMOLYTIC UREMIC SYNDROME (HUS) AND GASTROENTERITIS—PATHOPHYSIOLOGICAL AND DIAGNOSTIC CLUES
2000
Effect of plasma and LPS on respiratory burst of neutrophils in septic patients
1998
Discriminative power of inflammatory markers for prediction of tumor necrosis factor-α and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points
2000
Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-α and interleukin-6 in patients with sepsis
1999
Discriminative power of inflammatory markers for prediction of tumor necrosis factor-α and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points
2000
Human peripheral blood mononuclear cells express mRNA for procalcitonin; modulation by lipopolysaccharides and sepsis related cytokines
1998
ACCP/SCCM Consensus Conference definitions correlate better with procalcitonin than tumor-necrosis-factor-α and interleukin-6
1996